ACCORD HEALTHCARE INC, Kirkland, QC

With an extensive presence in North America, Europe, South America, Australia, New Zealand and South Africa and more recently in the MENA and Asia Pacific region, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies. With a robust product portfolio in growth oriented therapies, such as Oncology, Cardiology, Neurology, Nephrology, Urology, Psychiatry, Diabetology, Pain management and Gastroenterology and over 5500 product approvals (as of April, 2015) in various markets, Accord’s sales, marketing and distribution network now reaches over 60 countries.
Accord has grown both in organic & inorganic way towards expanding its product portfolio and operations in various parts of the world. Our North America and European operations were started with a strategic vision to create a global brand in the world’s largest pharmaceutical markets, supported by a commercial infrastructure that enables us to bring our high quality yet affordable products to patients. The same philosophy is extended to other regions of the world.
Today, Accord is marketing over 130 products all over the world and this number is going to increase significantly over the next few years considering our strong pipeline of products awaiting marketing approval from health & regulatory authorities and products in the development pipeline. Our large and growing portfolio allows us to compete with some of the biggest portfolios in the industry as well as helps to extend our presence into new markets.